Patent details

EP3071219 Title: METHODS OF TREATING ANTIBODY-MEDIATED REJECTION IN ORGAN TRANSPLANT PATIENTS WITH C1-ESTERASE INHIBITOR

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3071219
WO Application Number:
US2014066784
Type:
European Patent Granted for NL
Status:
Revoked
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP14809567.2
WO Publication Number:
WO2015077543
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
21/11/2014
Grant date:
14/11/2018
EP Publication Date:
28/09/2016
WO Publication Date:
28/05/2015
Claims Translations Received Date:
Claims Translation B1 Received Date:
31/01/2019
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
14/11/2018
EP B1 Publication Date:
14/11/2018
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
20/11/2034
Lapsed By Expiration Date:
Patent Validated Date:
09/03/2019
Revocation Date:
19/11/2024
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
17/06/2021
 
 

 

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka, Japan (JP)

Historical Applicant/holder

From:
17/04/2020
To:
17/06/2021

 

Name:
Shire Viropharma LLC
Address:
300 Shire Way, 02421, Lexington, MA, United States of America (US)

From:
14/11/2018
To:
17/04/2020

 

Name:
Shire Viropharma Incorporated
Address:
300 Shire Way, Lexington MA 02421, United States of America (US)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
08/03/2019
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
BROOM, Colin
Address:
Devon, PA 19333, United States of America (US)

2

Name:
UKNIS, Marc, E.
Address:
Chadds Ford, PA 19317, United States of America (US)

Priority

1

Priority Patent Number:
201462029086 P
Priority Date:
25/07/2014
Priority Country:
United States of America (US)

2

Priority Patent Number:
201361907550 P
Priority Date:
22/11/2013
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 38/55; A61K 39/395; A61P 37/00; A61K 35/16;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
07/25
Publication date:
12/02/2025
Description:
Lapse or annulment

2

Bulletin Heading:
CO
Journal edition number:
27/21
Publication date:
07/07/2021
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
CO
Journal edition number:
17/20
Publication date:
22/04/2020
Description:
Changes in the Netherlands Patent Register

4

Bulletin Heading:
EP3
Journal edition number:
11/19
Publication date:
13/03/2019
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

5

Bulletin Heading:
EP2
Journal edition number:
47/18
Publication date:
14/11/2018
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202507
Publication date:
12/02/2025
Description:
Revocation of the European patent

2

Issue number:
201851
Publication date:
19/12/2018
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
201846
Publication date:
14/11/2018
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202101205A
Date Registered:
17/06/2021
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Baker & McKenzie Amsterdam N.V.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka, Japan (JP)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of Legal Entity
Deed Number:
RC202000778A
Date Registered:
17/04/2020
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Shire Viropharma LLC
Address:
300 Shire Way, 02421, Lexington, MA, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
22/10/2024
Last Annual Fee Paid Number:
11
Last Annual Fee Paid Amount:
500 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
08/03/2019 Outgoing Correspondence Letter no formal defects 1 PDF /6/0/8/9/3/0800339806/docs/ep14809567.2_1_258213l271.pdf
31/01/2019 Claims First filed claims 2 PDF /6/0/8/9/3/0800339806/docs/ep14809567.2_0_claims20190131134509063.pdf